Venus Remedies Limited
VENUSREM.BO News Today: Stay Updated with the Latest Venus Remedies Limited News in Real Time
Find VENUSREM.BO news now at Meyka AI. Stay informed with the latest Venus Remedies Limited stocks updates, including price news, market analysis, and expert insights.

Closed: 0287.HK Winfair Investment HKSE HK$4.08 24 Mar 2026: oversold bounce
Meyka view on 0287.HK stock at HK$4.08 on 24 Mar 2026 highlights oversold bounce and an 8.33% one-year upside forecast

AI Facial Recognition March 24: Evidence Letters Signal Lawsuit Risk
AI facial recognition faces rising legal risk after evidence letters in the Angela Lipps case. What this means for HK policy, vendor contracts, and municipal insurance.

GBZ.AX GBM Resources ASX A$0.029 pre-market 25 Mar 2026: Oversold bounce, +86% model upside
Pre-market GBZ.AX stock at A$0.029 shows oversold bounce signs; Meyka AI model projects A$0.054 (β+86%) outlook

JP (Jupai Holdings, NYSE) at $0.38 intraday 24 Mar 2026: Oversold bounce watch for $0.55 target
Intraday oversold bounce setup for JP stock at $0.38 on 24 Mar 2026 with Meyka AI forecast and trade plan

BLS.NS stock closes at INR 259.40 on NSE 24 Mar 2026: heavy volume, momentum
BLS.NS stock ends at INR 259.40 on 24 Mar 2026 with volume 83,597,779; Meyka AI forecast and grade

5AU.SI AP Oil (SES) +6.87% to S$0.14 on Mar 24 2026: volume spike may continue
5AU.SI stock jumps to S$0.14 on Mar 24 2026 with **volume** pick-up; quick fundamentals and Meyka AI forecast for investors

23.08% pre-market rise: EMU.AX stock A$0.032 on ASX signals renewed buying interest
EMU.AX stock jumps 23.08% pre-market to A$0.032 on ASX; volume surge and forecasts point to a possible 34.78% 12βmonth upside

RAJGASES.BO Rajasthan Gases Limited (BSE) at INR 42.67: oversold bounce
RAJGASES.BO stock at INR 42.67; oversold bounce thesis, PE 6.71 and Meyka AI forecast INR 63.85

Varia US Properties (VARN.SW, SIX) CHF18.00 Mar 2026: earnings may reset price
Intraday update on VARN.SW stock at CHF18.00 ahead of Mar 26 earnings; grade, valuation and Meyka forecast